Magstim Academy Lecture Series – Rhythm and Acceleration – recent advances in TMS treatment for mood disorders. Mark George, MD, Nolan Williams, MD and Martijn Arns, PhD will present on their recently published and on-going TMS studies.
Magstim® TMS has launched the very first Transcranial Magnetic Stimulation navigation system specifically developed for the clinical market.
A 34 year old man, who suffered from depression for 20 years and endured 13 courses of antidepressants with no effect, is calling for greater awareness of a non-invasive treatment that treats depression with magnetic pulses to stimulate brain activity.
Magstim has received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for Major Depressive Disorder with its Horizon® TMS Therapy systems.
Neuromodulation has been studied in various forms for decades resulting in a range of clinical therapies and emerging applications including transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS) and electroconvulsive therapy (ECT) to name a few. We hope to answer some questions about neuromodulation here.
Effective, non-invasive & optimized for patient comfort.
Magstim® TMS Therapy provides higher performance, enhanced support and a higher ROI;
resulting in reduced costs and increased revenue for your TMS machine.